Editas Medicine (EDIT) Other Non Operating Income (2015 - 2025)
Editas Medicine's (EDIT) quarterly Other Non Operating Income came in at -$1000.0 in Q3 2025, up 80.0% year-on-year from -$555.56 in Q3 2024, and up 99.94% on a QoQ basis from -$1.8 million in Q2 2025.
Editas Medicine (EDIT) Other Non Operating Income (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Other Non Operating Income data on file, last reported at -$1000.0 in Q3 2025.
- On a quarterly basis, Other Non Operating Income rose 80.0% year-over-year to -$1000.0 in Q3 2025; TTM through Sep 2025 was -$2.2 million, a 15521.43% decrease from a year earlier, with the FY2024 full-year figure at -$3000.0, up 99.81% from the prior year.
- Other Non Operating Income for Q3 2025 stood at -$1000.0, up from -$1.8 million in the prior quarter.
- Over the last five years, Other Non Operating Income for EDIT reached as high as $235000.0 in Q2 2022 and fell as low as -$1.8 million in Q2 2025.
- Historically, Other Non Operating Income has averaged -$208666.7 across 5 years, with a median of -$2000.0 in 2021.
- Across the five-year window, Other Non Operating Income soared 23600.0% in 2022 and plunged 175700.0% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$1000.0 in 2021, then slumped by 300.0% to -$4000.0 in 2022, then tumbled by 250.0% to -$14000.0 in 2023, then surged by 78.57% to -$3000.0 in 2024, then surged by 66.67% to -$1000.0 in 2025.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$1000.0 in Q3 2025, -$1.8 million in Q2 2025, and -$425000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -425,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Jun 30, 2023 | -7,000.00 |
| Mar 31, 2023 | -1.58 Mn |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 235,000.00 |
| Mar 31, 2022 | -234,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 3.15 Mn |
| Sep 30, 2020 | -1.40 Mn |